Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepivacaine vs. Bupivacaine in Total Knee Arthroplasty
NCT02980926Phase 4Completed
- Sponsor
- Henry Ford Health
- Start
- Dec 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of mepivacaine (2 arms), sponsored by Henry Ford Health. Primary endpoint: Return of motor and sensory function at 6 hours. Started Dec 2016; status: completed.
02
Drugs
mepivacaine
Beyond the preview
Go deeper on NCT02980926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980926.